Efficacy and safety of bosutinib in chronic phase CML patients developing pleural effusion under dasatinib therapy

Ann Hematol. 2019 Nov;98(11):2609-2611. doi: 10.1007/s00277-019-03802-y. Epub 2019 Sep 16.

¹ Division of Hematology and BMT, Department of Medical Area, University of Udine, Udine, Italy. [email protected].
² Department of Hematology, Tor Vergata University Hospital, Rome, Italy.
³ Hematology Unit, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy.
⁴ Institute of Hematology, Università Cattolica Sacro Cuore, Rome, Italy.
⁵ Hematology and BMT Unit, Department of Hematology and Oncology, G. da Saliceto Hospital, Piacenza, Italy.
⁶ Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
⁷ Hematology Unit, Federico II Hospital, University of Naples, Naples, Italy.
⁸ Hematology and Clinical Immunology, Department of Medicine, Padua School of Medicine, Padua, Italy.
⁹ Section of Hematology, Department of Medicine, University of Verona, Verona, Italy.
¹⁰ Hematology Unit, Ospedale Cardarelli, Naples, Italy.
¹¹ Hematology Unit and BMT Center, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
¹² Division of Hematology and BMT, Department of Medical Area, University of Udine, Udine, Italy.

No abstract available

Publication types